Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Melanoma 24Neoplasm Metastasis 11Skin Neoplasms 10Neoplasms 8Kidney Neoplasms 6Carcinoma, Renal Cell 4Breast Neoplasms 4Uveal Melanoma 3Lymphoma, Non-Hodgkin 3Uterine Cervical Neoplasms 2Rectal Neoplasms 2Neuroblastoma 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Leukemia, Lymphocytic, Chronic, B-Cell 2HIV Infections 2Gastrointestinal Neoplasms 2Eye Neoplasms 2Colonic Neoplasms 2Burkitt Lymphoma 2Acquired Immunodeficiency Syndrome 2Vulvar Neoplasms 1Vulvar Diseases 1Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1

Interventions

Fluorouracil 2Colposcopy 2motexafin lutetium 1fludarabine phosphate 1fludarabine 1aldesleukin 1Vaginal Smears 1Respiratory Function Tests 1Prochlorperazine 1Positron-Emission Tomography 1Polymerase Chain Reaction 1Photochemotherapy 1Papanicolaou Test 1Ondansetron 1O(6)-codeine methyl ether 1Meperidine 1Magnetic Resonance Imaging 1Loperamide 1Isotretinoin 1Interleukin-2 1Innovar 1Indomethacin 1Imiquimod 1Hydroxyzine 1Granisetron 1Fluorophotometry 1Electrocardiography 1Droperidol 1Doxylamine 1Diphenoxylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Uterine Cervical Dysplasia × Interleukin-2 × Clear all
NCT02858310 2026-03-09

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
224 enrolled 15 charts
Gynecologic

Carcinoma in Situ, Uterine Cervical Dysplasia, Vulvar Diseases, Vulvar Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡